Several Headwinds Dragged Repligen Corporation (RGEN) in Q2
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here.
Repligen Corp (RGEN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 1,058,169 | $156,441,072 | -7% | 0.61% |
| 2. | Lee Munder Capital Group Lee Munder | 0 | $0 | 0% | |
| 3. | Roubaix Capital Christopher Hillary | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $125.46 | 700 | 4,613 | 2024-06-14 | Filing | ||
| $124.54 | 915 | 3,913 | 2024-06-14 | Filing | ||
| $125.45 | 1,200 | 4,668 | 2024-06-14 | Filing | ||
| $124.08 | 2,000 | 165,177 | 2024-06-14 | Filing | ||
| $156.18 | 500 | Director | 1,611 | 2023-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $146.67 | 604 | 139,840 | 2024-09-10 | Filing | ||
| $145.95 | 10,723 | 140,444 | 2024-09-10 | Filing | ||
| $144.88 | 9,369 | 151,167 | 2024-09-10 | Filing | ||
| $143.77 | 1,495 | 160,536 | 2024-09-10 | Filing | ||
| $158.85 | 175 | 12,288 | 2024-08-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,859,645 | $1,413,164,160 | 0.03% | |
| 2. | 5,078,294 | $913,077,261 | 0.01% | |
| 3. | 1,882,516 | $338,476,332 | 0.02% | |
| 4. | 1,703,618 | $306,310,516 | 0.01% | |
| 5. | 1,568,792 | $282,068,677 | 0.32% |
News See All
Reasons for the Decline of Repligen (RGEN) in Q2
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.
Repligen Corporation (RGEN) Fell Due to CEO Transition
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Repligen Corporation (RGEN) Benefitted From Drug Approval
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q2 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen Corporation's Second Quarter of 2024 Earnings Conference Call. [Operator Instructions].
Should You Consider Investing in Repligen Corporation (RGEN)?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” second-quarter 2024 investor letter. A copy of the same can be downloaded here.
20 Most Profitable Stocks of the Last 20 Years
The stock market has a long history of generating wealth for investors. While past performance doesn't guarantee future results, studying successful companies can provide valuable insights.
Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29.
Billionaire Hedge Funds
